These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 17714414

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reduction of disulfide bonds within anti-D results in enhanced Fcgamma receptor blockade.
    Kruspe AS, Katsman Y, Sakac D, Chagneau C, Glistvain A, Langler RF, Branch DR.
    Transfusion; 2009 May; 49(5):928-36. PubMed ID: 19170994
    [Abstract] [Full Text] [Related]

  • 3. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells.
    Rampersad GC, Suck G, Sakac D, Fahim S, Foo A, Denomme GA, Langler RF, Branch DR.
    Transfusion; 2005 Mar; 45(3):384-93. PubMed ID: 15752156
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ, Scott-Moncrieff C, Christian J, Snyder P, Kelly K, Glickman L.
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [Abstract] [Full Text] [Related]

  • 7. NA1/NA2 antisera inhibit FcgammaRI- but not FcgammaRII- mediated phagocytosis.
    Flesch BK, Maass W, Neppert J.
    Vox Sang; 1998 Dec; 75(3):247-52. PubMed ID: 9852415
    [Abstract] [Full Text] [Related]

  • 8. Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cell.
    Flesch BK, Vöge K, Henrichs T, Neppert J.
    Vox Sang; 2001 Dec; 81(2):128-33. PubMed ID: 11555474
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ, Dekkers G, Kustiawan I, van de Bovenkamp FS, Geissler J, Plomp R, Wuhrer M, Vidarsson G, Rispens T, van den Berg TK, Kuijpers TW.
    Blood; 2014 Dec 11; 124(25):3709-18. PubMed ID: 25352126
    [Abstract] [Full Text] [Related]

  • 10. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R, Lemieux R, Tremblay T, St-Amour I.
    Br J Haematol; 2004 Oct 11; 127(1):90-6. PubMed ID: 15384982
    [Abstract] [Full Text] [Related]

  • 11. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2007 Oct 11; 56(10):3399-411. PubMed ID: 17907194
    [Abstract] [Full Text] [Related]

  • 12. Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration.
    Shoham-Kessary H, Gershon H.
    Vox Sang; 1999 Oct 11; 77(1):33-9. PubMed ID: 10474088
    [Abstract] [Full Text] [Related]

  • 13. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura.
    Aubin E, Lemieux R, Bazin R.
    Br J Haematol; 2007 Mar 11; 136(6):837-43. PubMed ID: 17341270
    [Abstract] [Full Text] [Related]

  • 14. Enhanced antibody-dependent cellular phagocytosis by chimeric monoclonal antibodies with tandemly repeated Fc domains.
    Nagashima H, Ootsubo M, Fukazawa M, Motoi S, Konakahara S, Masuho Y.
    J Biosci Bioeng; 2011 Apr 11; 111(4):391-6. PubMed ID: 21215693
    [Abstract] [Full Text] [Related]

  • 15. [Photometric detection of erythrocyte phagocytosis in the monocyte-macrophage assay].
    Sibroswki W, Cassens U, Kühnl P.
    Beitr Infusionsther; 1990 Apr 11; 26():333-5. PubMed ID: 1703867
    [Abstract] [Full Text] [Related]

  • 16. Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.
    Sárváry A, Szucs S, Balogh I, Becsky A, Bárdos H, Kávai M, Seligsohn U, Egbring R, Lopaciuk S, Muszbek L, Adány R.
    Cell Immunol; 2004 Apr 11; 228(2):81-90. PubMed ID: 15219459
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR, Song S, Siragam V, Lazarus AH.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):710-3. PubMed ID: 16933274
    [Abstract] [Full Text] [Related]

  • 18. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A, Assinger A, Hacker S, Hoetzenecker K, Schmid W, Lang G, Wolfsberger M, Steinlechner B, Bielek E, Lalla E, Klepetko W, Volf I, Ankersmit HJ.
    Br J Dermatol; 2008 Sep 15; 159(3):578-84. PubMed ID: 18565176
    [Abstract] [Full Text] [Related]

  • 19. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR, Lazarus AH.
    Transfus Med Rev; 2008 Apr 15; 22(2):103-16. PubMed ID: 18353251
    [Abstract] [Full Text] [Related]

  • 20. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
    Deng R, Balthasar JP.
    Int J Pharm; 2005 Nov 04; 304(1-2):51-62. PubMed ID: 16171959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.